Welcome to Purinomia

Biologicals and small molecule development to target key ectonucleotidases

Targeting purinergic signaling

Biologicals and small molecule development to target key ectonucleotidases for treatment of cancer, autoimmunity, inflammatory disease and metabolic syndrome.

Subscribe

Contact information

Purinomia

*simoncrobson@gmail.com

Monday - Sunday: 7am - 6pm


Email